Preclinical pharmacological profile of nomegestrol acetate, a synthetic 19-nor-progesterone derivative
<p>Abstract</p> <p>Background</p> <p>Nomegestrol acetate (NOMAC), a synthetic progestogen derived from 19-nor-progesterone, recently completed clinical trials for use with 17beta-estradiol in a new monophasic combined oral contraceptive. In this review, published as wel...
Main Author: | van Diepen Harry A |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-10-01
|
Series: | Reproductive Biology and Endocrinology |
Subjects: | |
Online Access: | http://www.rbej.com/content/10/1/85 |
Similar Items
-
Nomegestrol acetate - a new progestogen for oral contraception (a review)
by: V N Prilepskaya, et al.
Published: (2015-06-01) -
Pilot Data on the Feasibility And Clinical Outcomes of a Nomegestrol Acetate Oral Contraceptive Pill in Women With Premenstrual Dysphoric Disorder
by: Emily Robertson, et al.
Published: (2021-09-01) -
Efeito da inserção de implante anticoncepcional contendo acetato de nomegestrol sobre a função ovariana, muco cervical e penetração espermática Effects of a contraceptive implant containing nomegestrol acetate on ovarian function, cervical mucus and sperm penetration
by: Ione Cristina Barbosa, et al.
Published: (2004-07-01) -
Metformin Enhances Nomegestrol Acetate Suppressing Growth of Endometrial Cancer Cells and May Correlate to Downregulating mTOR Activity In Vitro and In Vivo
by: Can Cao, et al.
Published: (2019-07-01) -
Nomegestrol Acetate Suppresses Human Endometrial Cancer RL95-2 Cells Proliferation In Vitro and In Vivo Possibly Related to Upregulating Expression of SUFU and Wnt7a
by: A-ying Ma, et al.
Published: (2017-06-01)